Le Li

机构：Fujian Normal University, Fujian Institute of Research on the Structure of Matter · ORCID：0000-0003-3849-4854

发表论文 106 篇 · 总被引 2002 次 · h-index 23

代表论文

• Tertiary lymphoid structures in HCC: Influence on immune cell profiles in tumors and on efficacy of adjuvant PD-1 inhibitor therapy after hepatectomy (2025 · Hepatology · 被引 15)
• Treatment Duration of Adjuvant Immune Checkpoint Inhibitors in Hepatocellular Carcinoma Patients at High Risk of Recurrence after Resection: A Prospective, Multicentric Cohort Study (2024 · Liver Cancer · 被引 14)
• Adjuvant Therapy for Hepatocellular Carcinoma After Curative Treatment: Several Unanswered Questions (2024 · Journal of Clinical and Translational Hepatology · 被引 14)
• The efficacy and safety of tislelizumab with or without tyrosine kinase inhibitor as adjuvant therapy in hepatocellular carcinoma with high-risk of recurrence after curative resection (2025 · Frontiers in Immunology · 被引 4)
• Association between Hematocrit and Acute Kidney Injury in Patients with Acute Myocardial Infarction (2024 · Reviews in Cardiovascular Medicine · 被引 4)
• Natural product nanozymes of herbal extract galangin in managing hepatocellular carcinoma (2024 · Frontiers in Chemistry · 被引 4)